Major expectations from Pharma 2030 Strategy in Russia 2019
One half of respondents in Russia stated they expected the development and introduction of new medicines and pharmaceutical goods on the market from the Pharma 2030 Strategy, according to a survey from June 2019. Furthermore, almost 30 percent of the polled foresaw a decrease in imports of medical goods to Russia and an increase of local production.
